Article
Clinical implications of mutation analysis in primary hyperoxaluria type 1.
Kidney international - 1 Aug 2004
van Woerden Christiaan S, Groothoff Jaap W, Wijburg Frits A, Annink Carla, Wanders Ronald J A, Waterham Hans R
Abstract excerpt
BACKGROUND: Primary hyperoxaluria type 1 (PH1) is an inborn error of glyoxylate metabolism with an extensive clinical and genetic heterogeneity. Although over 50 disease-causing mutations have been identified, the relationship between genotype and clinical outcome remains unclear. The aim of this study was to determine this association in order to find clues for improvement of patient care. METHODS: AGXT mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
